Lannett (LCI) Tops Q2 EPS by 2c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. FIX
9. TSCO
10. BE

Go back to Lannett (LCI) Tops Q2 EPS by 2c

LANNETT REPORTS FISCAL 2022 FOURTH-QUARTER, FULL-YEAR FINANCIAL RESULTS

August 24, 2022 4:15 PM EDT

Q4 Business and Financial Highlights:

Net Sales were $74.2 MillionAdjusted Gross Margin Better than Expected, Improved vs Q3 Cash Was $88 Million at June 30Completed Major Elements of November 2021 Restructuring Plan

Pipeline Updates:

Pivotal Biosimilar Insulin Glargine Clinical Trial Over 90% Complete, Top-line Results Anticipated by Year End; BLA Filing On Track for First Half of 2023Expect to File IND for Biosimilar Insulin Aspart by First Half of 2023Generic FLOVENT®... More